Kinetics of lipid bilayer permeation of a series of ionisable drugs and their correlation with human transporter-independent intestinal permeability

Katharina F. Hermann,Claudia S. Neuhaus,Virgine Micallef,Björn Wagner,Maja Hatibovic,Hélène E. Aschmann,Franziska Paech,Rubén Alvarez-Sanchez,Stefanie D. Krämer,Sara Belli
DOI: https://doi.org/10.1016/j.ejps.2017.03.040
IF: 5.112
2017-06-01
European Journal of Pharmaceutical Sciences
Abstract:For low molecular weight drugs, lipid bilayer permeation is considered the major route for in vivo cell barrier passage. We recently introduced a fluorescence assay with liposomes to determine permeation kinetics of ionisable compounds across the lipid bilayer by monitoring drug-induced pH changes inside the liposomes. Here, we determined the permeability coefficients (P<sub>FLipP</sub>, FLipP for "Fluorescence Liposomal Permeability") across 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) bilayers of 35 ionisable drugs at pH6.0 and compared them to available in vivo human jejunal permeability (P<sub>eff</sub>) data. P<sub>FLipP</sub> values were furthermore compared with published Caco-2 cell permeability coefficients (P<sub>Caco-2</sub>), permeability coefficients determined with the parallel artificial membrane permeability assay (PAMPA) and with log D (pH6.0). The log P<sub>FLipP</sub>, corrected for predicted para-cellular diffusion, and log P<sub>Caco-2</sub> correlated best with log P<sub>eff</sub>, with similar adjusted R<sup>2</sup> (0.75 and 0.74, n=12). Our results suggest that transporter-independent intestinal drug absorption is predictable from liposomal permeability.
pharmacology & pharmacy
What problem does this paper attempt to address?